Renata de Sá Brito FrÓes

8PUBLICATIONS
78CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 18, 2025
Linking histological healing to quality of life: real-world insights into golimumab therapy in ulcerative colitis.

Rodrigo Galhardi Gasparini, Carlos Taxonera, Antônio José Tibúrcio Alves Júnior

|Mar 19, 2025
Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety.

Rogério Serafim Parra, Renata de Sá Brito Fróes, Daniela Oliveira Magro

|Apr 29, 2024
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study.

Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Matheus Freitas Cardoso de Azevedo

|Feb 21, 2024
Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB.

Renata de Sá Brito Fróes, Adriana Ribas Andrade, Mikaell Alexandre Gouvea Faria

|Mar 30, 2023
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).

Marcello Imbrizi, Júlio Pinheiro Baima, Matheus Freitas Cardoso de Azevedo

Pageof 2